Bayer Oncology Support Programs
Bayer offers drug-specific programs to assist patients with access and resources. A complete list of Bayer oncology products and their related assistance programs is provided in the Table.
Bayer Oncology Support Programs
Aliqopa Resource Connections
The Aliqopa Resource Connections, or ARC Program, offers comprehensive access, reimbursement support, and patient assistance services to patients taking Aliqopa to include:
- Bayer US Patient Assistance Foundation for qualified uninsured or underinsured patients
- Temporary Patient Assistance Program for patients whose coverage is delayed or who experience a temporary lapse in coverage for Aliqopa
- Aliqopa $0 Co-Pay Program for eligible patients with commercial insurance.
To learn more or to enroll your patient in the ARC Program, call 833-254-7672 or visit Aliqopa Resource Connections.
Access Services by Bayer
Access Services by Bayer is a free support program available to eligible patients who have been prescribed Nexavar, Nubeqa, Stivarga, Vitrakvi, or Xofigo. Services are drug-specific and may include:
- Oncology $0 Co-Pay Program assistance for eligible, commercially insured patients
- Benefit verification/prior authorization denial and appeal information
- Pharmacy coordination
- Alternate coverage research for the uninsured and underinsured
- Access and reimbursement support
- Referrals to the Bayer US Patient Assistance Foundation for patients who are uninsured or underinsured and meet certain eligibility criteria.
For more information or to enroll your patient in Access Services by Bayer, call 800-288-8374 or see Table for drug-specific links.
Oncology $0 Co-Pay Program
The Oncology $0 Co-Pay Program allows patients to fill their prescriptions with no out-of-pocket costs for eligible, commercially insured patients.
To enroll your patient in the Oncology $0 Co-Pay Program, please see Table for drug-specific links.
Bayer US Patient Assistance Foundation
The Bayer US Patient Assistance Foundation is a charitable organization that helps eligible patients get their Bayer prescription medicine at no cost. Patients who have been prescribed Aliqopa, Nexavar, Nubeqa, Stivarga, or Vitrakvi.